Product NDC: | 0053-7670 |
Proprietary Name: | Albuminar-5 |
Non Proprietary Name: | Albumin (Human) |
Active Ingredient(s): | 2.5 g/50mL & nbsp; Albumin (Human) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0053-7670 |
Labeler Name: | CSL Behring LLC |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA103955 |
Marketing Category: | BLA |
Start Marketing Date: | 20090106 |
Package NDC: | 0053-7670-06 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (0053-7670-06) > 50 mL in 1 VIAL, GLASS |
NDC Code | 0053-7670-06 |
Proprietary Name | Albuminar-5 |
Package Description | 1 VIAL, GLASS in 1 CARTON (0053-7670-06) > 50 mL in 1 VIAL, GLASS |
Product NDC | 0053-7670 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | Albumin (Human) |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090106 |
Marketing Category Name | BLA |
Labeler Name | CSL Behring LLC |
Substance Name | ALBUMIN (HUMAN) |
Strength Number | 2.5 |
Strength Unit | g/50mL |
Pharmaceutical Classes | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |